[The use of mood stabilizers in preventive treatment of patients with schizoaffective disorders].

Autor:	Chritinin DF, Sumarokova MA
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2014; Vol. 114 (10), pp. 63-7.
Abstrakt:	Objective: To study an effect of combination therapy consisting of mood stabilizers on the quality of remission in patients with schizoaffective disorders. Material and Methods: Authors examined 56 outpatients with ICD-10 diagnosis of schizoaffective disorder (F25). Patients in remission received anti-relapse therapy with antipsychotics and were not treated with mood stabilizers for at least two years, and then they received a combined anti-relapse therapy, including both antipsychotics and mood stabilizers. Results and Conclusion: The combined use of pharmacotherapy creates a better remission. No statistically significant differences in the effect of different groups of mood stabilizers on the average duration of remission are identified. The inclusion of mood stabilizers in the scheme of preventive treatment has no effect on the average duration of subsequent hospitalization. Mood stabilizers are effective in the prevention of suicidal behavior in patients with schizoaffective disorder, they reduce the risk of disability in patients with schizoaffective disorder and increase compliance.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu